The PHOENIX trial is a European, placebo-controlled, Phase III study treating patients in catecholamine-resistant, distributive shock with the Nitric Oxide (NO) scavenger PHP / Hemoximer. The study …
Curacyte – PHOENIX Phase III trial of PHP for distributive shock to continue after positive midpoint recommendation from DMB
Munich, March, 28th 2011 - The PHOENIX trial is a European, placebocontrolled, Phase III study treating catecholamine-resistant patients in distributive shock with the Nitric Oxide (NO) scavenger …